ARG Laboratories, Inc.

Warning LetterOpen

United StatesFEI 3002556034Issued Jun 11, 2024Office of Pharmaceutical Quality Operations, Division II

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3002556034.

Violations0

Issue DateJun 11, 2024

Product TypeDrugs

StatusOpen

Letter Details

Firm: ARG Laboratories, Inc.
Location: United States
FEI Number: 3002556034
Country: United States
Issue Date: June 11, 2024
Issuing Office: Office of Pharmaceutical Quality Operations, Division II
Product Type: Drugs
Status: Open

Summary

Based on limited metadata, ARG Laboratories, Inc., a drug manufacturer, received an FDA Warning Letter on June 11, 2024, though specific violation details are not available in the metadata provided. The letter falls under FDA's drug product regulatory authority, though the specific issuing office and detailed subject matter could not be determined from the available information. Without access to the full letter text, the precise nature of the compliance issues cannot be described. Companies receiving such warnings typically face citations for manufacturing, quality control, or labeling deficiencies that require prompt corrective action.

ARG Laboratories, Inc. FDA Warning Letter, June 11, 2024